The deciding contrast is between cost-effectiveness and cost-benefit analysis, and the giveaway is how each one expresses benefit.
Cost-effectiveness analysis (CEA) keeps the cost side in money but leaves the benefit side in natural, clinical units: life-years gained, cases prevented, deaths averted. When those natural units are weighted for quality of life, you get the QALY, the most complete CEA measure.
Cost-benefit analysis (CBA) is different in one crucial way: it forces the benefit into monetary terms so it can be subtracted from cost, so it does not use natural units. That eliminates option $d$.
Program budgeting ($a$) and network analysis ($b$) are not outcome-valuation methods at all, they are planning and scheduling tools, so they do not fit.
The method that measures benefit in natural units is cost-effective analysis, option $c$.
Ref: Park's PSM, 24th ed., p. 908.